Effect of subcutaneous Tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 Randomized Clinical Trial
The temporal pattern of nausea is clinically important for patient counseling
Research shows that by week four, roughly 60-70% of men report meaningful improvement in nausea and other early symptoms, even while continuing their prescribed dose
If the results confirm the Phase 2 findings, we're looking at a medication that could help patients lose nearly a quarter of their body weight, a threshold that begins to rival surgical outcomes
The timeline is unique to you, depending on your skins starting point, your goals, and how your body responds to the treatment
You find that dynamic in I&I today